Lensar price target lowered to $8 from $12 at BTIG

BTIG analyst Ryan Zimmerman lowered the firm’s price target on Lensar to $8 from $12 and keeps a Buy rating on the shares. The firm is modeling revenue of $10M in Q2, assuming the sale of 8 ALLY systems and a blended ASP of $240.20 per procedure, but says the private placement does not address the limited liquidity in shares today, the analyst tells investors in a research note.